Received for publication January 15, 1965 ATTEMPTS to use radioactive fluorene disulphonamides in the diagnosis of internal cancer failed to prove their highly specific affinity to tumour tissue which could localize and determine a neoplasm at its early stage of development. It was found, however, that some fluorene disulphonamido derivatives might be used to determine an affected phagocytic function of the reticulo-endothelial system in the presence of tumour (Argus, Hewson and Ray, 1956;  Argus, 1961; Malejka, Argus and Ray, 1963; Argus, Hudson, Seepe, Kane and Ray, 1962; Malejka, 1962) . N,N'-bis(naphthalene)-2,7-fluorene[35S]disulphonamide was the subject of particularly extensive studies; its diagnostic value was examined in mice bearing a transplanted squamous cell stomach carcinoma (Argus and Hewson, 1954) , in Syrian hamsters with sarcoma and in rats bearing Walker carcinosarcoma 256 (Argus, Hudson, Seepe, Kane and Ray, 1962) . In all cases, the concentration ratio of the disulphonamide in the liver and spleen of control animals and in the same organs of tumour-bearers exceeded 1. This revealed an impaired function of the liver and spleen in the presence of tumour. Examining N,N'-bis(sulphamoyl-phenyl)-2,7-fluorene[35S]disulphonamide it was found that the spleen of tumour-free rats localized 4 times more of this compound than the spleen of tumour-bearers (Malejka, 1962) . Comparison of the results for the naphthalene derivative in the animals bearing various tumours to its behaviour under stress conditions showed an opposite effect, consisting in a decreased uptake of the disulphonamide by the liver and spleen of control animals (Argus, Kane and Ray, 1960; Malejka, Argus and Ray, 1961) .
In the present investigation two known sulphonamido substituents: aminothiazole and guanidine were chosen for obtaining N,N'-bis(thiazole)-2,7-fluorene[35S]disulphonamide, I, and N,N'-bis(guanidine) (Argus and Hewson, 1954) (Argus, Kane and Ray, 1960) . In the present experiment brain was taken separately and 10 ml. of 0-25 N NaOH was added per g. of tissue. Radioactivity measurements were made in a gas-flow GM counter of low background with automatic sample changer from " Tracerlab ". A proportional gas and windowless counter was used. Its efficiency was 74.7 per cent. between Wistar rats bearing a transplanted Walker carcinosarcoma and tumourfree animals was compared. In order to obtain data which could be compared to those for the compounds tested previously (Argus, Kane and Ray, 1960; Malejka, Argus and Ray, 1961; Malejka, 1962) , this investigation was also conducted with a 6 hours' time interval between administration and killing. The details of these studies for compounds I and II are shown in Table I . Both concentrations, Polar substituents modify two aspects of the behaviour of the fluorene derivatives in the animal body. First, the introduction of either the free acidic groups, -SO3H and -COOH (Argus, 1953; Argus, 1961 Malejka, 1962 or basic groups (as in the presently described bis-guanidyl derivative, II) increase the solubility of these compounds. This is in agreement with the general physical-chemical phenomenon that the increase of the polar character increases the solubility of chemical compounds because of increased hydrogen-bonding capability with water molecules. Accordingly, -SO3NH2 groups, in which there is a relative equalization of the electric charges, were found to confer much less solubility to the carbon skeleton of such compounds than free acidic or basic groups (Argus, 1953 ; Argus and Hewson, 1954 ; and the present results). Secondly, the free acidic groups, -SO3H and -COOH, have been shown to confer tumour affinity to the fluorene and biphenyl compounds, from which fact the inference has been drawn that these compounds are bound at the cellular adsorption sites by basic proteins (Argus, 1961) . The fact that the presently-described bis-guanidyl derivative does not localize in tumour tissue gives strong support to this hypothesis.
The linking of thiazole rings to the two sulphonamido groups of fluorene-2,7-disulphonamide appears to favour the localization in tumour tissue. The concentration of N,N'-bis(thiazole)-2,7-fluorene[35S]disulphonamide in tumour tissue was 35,tg. per g. tissue which, calculated for the average weight of tumour, yielded 8.03 per cent of the given dose. Autoradiograms of tumour slides showed a considerable uptake of radioactivity by tumour cells and particularly by their nuclei (Kasprzak, Malejka, Gabryel, 1965) . The absolute value of the concentration of N,N'-bis(thiazole)-2,7-fluorene[35S]disulphonamide in tumour tissue was higher than for the other compounds of this group previously tested (Argus, Hudson, Seepe, Kane and Ray, 1962; Malejka, 1962) . The molecular weight of the thiazole derivative, amounting to 490.6, was the lowest; the naphthalene derivative had 576.5 and the sulphamoyl-phenyl derivative 634. However, in the case of the thiazole compound, the ratios of the radioactivity concentration in tumour tissue and in the liver or spleen or kidney were lower than 0.5. These data show once again that the presence of free acidic functional groups seems to be necessary for achieving better selective localization of the fluorene disulphonamide molecule in neoplasm.
In view of the differences in localization of N,N'-bis(thiazole)-2,7-fluorene-
[35S]disulphonamide, I, between the experimental and control animals, a comparison of the concentration of radioactivity in blood cells, blood plasma, liver, spleen, kidneys and urine of tumour-free Wistar rats and in the same tissues of tumour-bearers 6 hours after intravenous injection of compound I is given in Table II . On examining the concentration of the disulphonamide in blood cells and blood plasma of experimental and control animals, it was found that this compound transferred at a slower rate from the blood cells of tumour-bearers (ratio value 0.27), while it appeared at higher concentrations in the blood plasma of tumourfree rats (ratio value 1.42). The concentrations of radioactivity in liver were very high but close in both groups, showing slightly enhanced uptake by the tumour-bearers and giving a ratio of 0.87. This enhanced uptake was not, however, statistically significant (p _ 0.60). The ratio value 0-49 calculated for spleen showed that the organ of tumour-bearing rats localized twice as much radioactivity as the control group. Both ratios, for blood cells and spleen, are statistically significant (0.02 < p < 0.05). The phenomenon of greater uptake of the radioactive compound by the liver and spleen of tumour-bearing rats than by the same organs of controls may well be explained by the striking proliferation of reticulo-endothelial cells which had been observed on autoradiograms of liver and spleen in the presence of this tumour (Kasprzak, Malejka and Gabryel, 1965) . to tumour-bearing and tumour-free Wistar rats was studied. While the distribution of compound I is affected by the presence of tumour, compound II is excreted to urine in [73] [74] [75] [76] [77] [78] [79] [80] per cent of the dose applied. The thiazole derivative revealed an appreciable concentration in tumour-35 ,ug. per g. tissue which was about 8 per cent of the dose given. Blood cells, liver, spleen and kidneys of tumour-bearing animals showed a higher concentration of radioactivity than the same tissues of control rats. Hence, the phenomenon of impaired function of the reticulo-endothelial system in the presence of tumour was not demonstrated in this experiment. It seems, therefore, that all derivatives of fluorene-2,7-disulphonamide may not produce consistently the same type of reaction in the reticulo-endothelial system.
